‹ All Posts
SFP RESEARCH

9th Sep · SEBI-Registered Analyst

Torrent Pharmaceuticals

Diversified pharma with strong India and US businesses. R&D pipeline focused on complex generics and specialty medicines. Margin expansion is visible due to cost controls and brand strategy. Regulatory and price risks are sectoral challenges.

#WatchOutFor#TechnicalViews#FundamentalViews#Miscellaneous#EquityResearch
875 likes·88 comments